Patents by Inventor Eric Deutsch

Eric Deutsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12644346
    Abstract: A system that can include slips configured to selectively engage a tubular string that extends into a wellbore, a slips lifter configured to selectively raise or lower the slips, and a link configured to decouple the slips from the slips lifter when the slips are rotated relative to the slips lifter. A method that can include operations of coupling a slips lifter, via a link, to slips on a rig floor, engaging the slips to a tubular, rotating the slips relative to the slips lifter, and decoupling the slips from the slips lifter by decoupling a first element of the link from a second element of the link in response to rotation of the slips.
    Type: Grant
    Filed: December 18, 2024
    Date of Patent: June 2, 2026
    Assignee: Nabors Drilling Technologies USA, Inc.
    Inventors: Eric Deutsch, Johnny Harris, Nathan Rose
  • Patent number: 12590949
    Abstract: The present invention proposes a radiomics-based biomarker for detecting the presence and the density of tumor infiltrating CD8 T-cells in a solid tumor without having to use any biopsy of said tumor. The invention also proposes to use this information to assess the immune phenotype of said solid tumor. In a particular embodiment, the invention proposes to prognose the survival and/or the treatment efficiency of cancer patients treated with immunotherapy such as anti-PD-1/PD-L1 monotherapy.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: March 31, 2026
    Assignees: Institut National de la Sante et de la Recherche Medicale, Universite Paris-Saclay
    Inventors: Charles Ferte, Elaine Johanna Limkin, Roger Sun, Eric Deutsch
  • Publication number: 20260061029
    Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.
    Type: Application
    Filed: October 17, 2025
    Publication date: March 5, 2026
    Inventors: Jean-Luc PERFETTINI, Awatef ALLOUCH, Eric DEUTSCH
  • Patent number: 12514902
    Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: January 6, 2026
    Assignee: Institut Gustave-Roussy
    Inventors: Jean-Luc Perfettini, Awatef Allouch, Eric Deutsch
  • Patent number: 12511747
    Abstract: A method implemented by computer means for training a decision system for segmenting medical images from a training set of annotated medical images, the segments belonging to at least one class, each annotation of the medical images including quantitative information about a number of pixels of the image that belongs to each of the classes, the method using weakly-supervised algorithm based on a percentage of the pixels of the image belonging to a concerned class.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: December 30, 2025
    Assignees: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, CENTRALE SUPELEC
    Inventors: Marvin Lerousseau, Eric Deutsch
  • Publication number: 20250198244
    Abstract: A system that can include slips configured to selectively engage a tubular string that extends into a wellbore, a slips lifter configured to selectively raise or lower the slips, and a link configured to decouple the slips from the slips lifter when the slips are rotated relative to the slips lifter. A method that can include operations of coupling a slips lifter, via a link, to slips on a rig floor, engaging the slips to a tubular, rotating the slips relative to the slips lifter, and decoupling the slips from the slips lifter by decoupling a first element of the link from a second element of the link in response to rotation of the slips.
    Type: Application
    Filed: December 18, 2024
    Publication date: June 19, 2025
    Inventors: Eric DEUTSCH, Johnny HARRIS, Nathan ROSE
  • Publication number: 20240346713
    Abstract: A computer-implemented method for reconstructing a 3D image of a human body part studied of a subject from at least one 2D projection of the human body part studied of the subject and a generative network trained for reconstructing 3D images. The human body part may be the head and/or the neck.
    Type: Application
    Filed: April 12, 2024
    Publication date: October 17, 2024
    Applicants: THERAPANACEA, INSTITUT DE CANCEROLOGIE GUSTAVE ROUSSY, CENTRE LEON BERARD
    Inventors: Alexandre CAFARO, Quentin SPINAT, Eric DEUTSCH, Vincent GREGOIRE, Nikos PARAGIOS
  • Publication number: 20240346668
    Abstract: A computer-implemented method for generating a registered image (Breg) based on at least one first image of an object compliant with a source imaging modality and on at least one second image of the object compliant with a target imaging modality. The object may include a human body part, and the structures of interest may include stiff regions such as bones, cartilage, or tendons.
    Type: Application
    Filed: April 12, 2024
    Publication date: October 17, 2024
    Applicants: THERAPANACEA, INSTITUT DE CANCEROLOGIE GUSTAVE ROUSSY, CENTRE LEON BERARD
    Inventors: Amaury LEROY, Eric DEUTSCH, Vincent GREGOIRE, Nikos PARAGIOS
  • Publication number: 20240153085
    Abstract: A method implemented by computer means for training a decision system for segmenting medical images from a training set of annotated medical images, the segments belonging to at least one class, each annotation of the medical images including quantitative information about a number of pixels of the image that belongs to each of the classes, the method using weakly-supervised algorithm based on a percentage of the pixels of the image belonging to a concerned class.
    Type: Application
    Filed: March 11, 2022
    Publication date: May 9, 2024
    Applicants: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, CENTRALE SUPELEC
    Inventors: Marvin LEROUSSEAU, Eric DEUTSCH
  • Publication number: 20230218781
    Abstract: The present disclosure relates to the field of nanomedicine, in particular for treating cancers. The present disclosure more specifically provides new methods of treating undesirable M2-polarized macrophages and/or inducing M1 macrophage polarization in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of nanoparticles containing metallic elements.
    Type: Application
    Filed: September 18, 2020
    Publication date: July 13, 2023
    Inventors: Awatef ALLOUCH, Eric DEUTSCH, Jean-Luc PERFETTINI, François LUX, Olivier TILLEMENT
  • Patent number: 11642691
    Abstract: A pipe doping apparatus comprises a bucket assembly including a base and a bucket supported on the base and having an inside volume, a lubricating unit having at least one lubricant applicator inside the bucket; and a source of torque configured to rotate the bucket and/or the lubricating unit relative to a tubular. The apparatus may include a cleaning unit and/or a drying unit and the source of torque may be a fluid jet in either. At least one lubricant applicator may be retractable and may be actuated between a retracted position and an extended position by centripetal force. The apparatus may further include a positioning assembly supporting the base and the rotary bucket assembly and a controller connected to and controlling each of:—the positioning assembly, the cleaning unit, the drying unit, and the lubricating unit.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: May 9, 2023
    Assignee: NABORS DRILLING TECHNOLOGIES USA, INC.
    Inventors: Ronald Schanlaub, Keith Hager, Chris Magnuson, Eric Deutsch
  • Patent number: 11603568
    Abstract: Although tumor-associated macrophages have been extensively studied in the control of response to radiotherapy, the molecular mechanisms involved in the ionizing radiation-mediated activation of macrophages remain elusive. Here the present inventors show that ionizing radiation induces the expression of interferon-regulatory factor 5 (IRF5) promoting thus macrophage activation toward a pro-inflammatory phenotype. They reveal that the activation of the Ataxia telangiectasia mutated (ATM) kinase is required for ionizing radiation-elicited macrophage activation, but also for macrophage reprogramming after treatments with ?-interferon, lipopolysaccharide or chemotherapeutic agent (such as cis-platin), underscoring the fact that the kinase ATM plays a central role during macrophage phenotypic switching toward a proinflammatory phenotype. They further demonstrate that NADPH oxidase 2 (NOX2)-dependent ROS production is upstream to ATM activation and is essential during this process.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: March 14, 2023
    Assignee: Institut Gustave Roussy
    Inventors: Jean-Luc Perfettini, Eric Deutsch, Awatef Allouch
  • Publication number: 20230000801
    Abstract: A freeze-dried powder for preparing a thermogel including: from 1% to 35% of 2-[(3-aminopropyl)amino]ethanethiol or one of its pharmaceutically acceptable salt; from 40% to 85% of one or more poloxamer; and from 0.1% to 20% of one or more carbohydrate compound.
    Type: Application
    Filed: November 24, 2020
    Publication date: January 5, 2023
    Applicants: CLEVEXEL PHARMA, INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY
    Inventors: Denis BRICOUT, Xiuping WANG-ZHANG, Eric DEUTSCH, Céline CLEMENSON
  • Patent number: 11517575
    Abstract: The present invention is drawn to the use of Minaprine dihydrochloride and analogs thereof, for reducing tumor growth when administered to a patient suffering from cancer.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: December 6, 2022
    Assignee: Institut Gustave Roussy
    Inventors: Jean Luc Perfettini, Eric Deutsch, Catherine Brenner, Jean-Christophe Cintrat, Frederic Taran
  • Patent number: 11471463
    Abstract: The present invention is drawn to the use of the compounds highlighted in Tables 1 & 2 and analogs thereof, for enhancing IR-mediated cellular cannibalism in cancer cells. Said compounds are herein called “enhancers of IR-mediated cellular cannibalism”. They can be used to enhance tumor immunogenicity and/or to induce a significant protective anticancer immune response in subjects that will receive or that have received a radiotherapy treatment. In other words, said compounds can be used to potentiate a radiotherapy treatment in a subject in need thereof. Said compounds are preferably chosen in the group consisting of: Mebhydroline 1,5-napthalene disulfonate salt, Flurbiprofen, Minaprine dihydrochloride, Myricetin, Digoxin, Digitoxin, Lanatoside, LOPA87, VP331, RN-1-026, SG6163F, VP450, and VP43.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: October 18, 2022
    Assignee: Institut Gustave Roussy
    Inventors: Jean Luc Perfettini, Eric Deutsch, Catherine Brenner, Jean-Christophe Cintrat, Frederic Taran
  • Publication number: 20220257709
    Abstract: Identification of effective targets alleviating the programmed cell removal (PrCR) of tumor cells by macrophages is of very high interest. The present inventors have identified that the cyclin-dependent kinase inhibitor p21 protein is a strong regulator of the macrophage-mediated PrCR. Also, they showed that the adoptive transfer of p21 overexpressing monocytes induces macrophage PrCR and transition from an anti-inflammatory to a pro-inflammatory phenotype in vivo, delays cancer progression and increases significantly the overall survival of mice engrafted with cancer cells. The present invention therefore concerns therapeutic compositions comprising monocytes that over-express the cyclin-dependent kinase inhibitor p21 protein, and their use for treating mammals suffering from cancer, especially leukemia.
    Type: Application
    Filed: July 17, 2020
    Publication date: August 18, 2022
    Applicant: Institut Gustave-Roussy
    Inventors: Jean-Luc PERFETTINI, Awatef ALLOUCH, Eric DEUTSCH
  • Patent number: 11248424
    Abstract: A device and method for subterranean operations comprising a latch adapted to be coupled with a fingerboard of a drilling rig, the fingerboard including at least two fingers, wherein: the latch is selectively moveable between an open configuration and a closed configuration, the latch is adapted to selectively permit entrance of a first tubular into a tubular storage area between the at least two fingers when the latch is in the open configuration, and selectively maintain the first tubular in the tubular storage area when the latch is in the closed configuration, and the latch is spaced apart from the fingerboard.
    Type: Grant
    Filed: November 5, 2020
    Date of Patent: February 15, 2022
    Assignee: Nabors Drilling Technologies USA, Inc.
    Inventors: Christopher Magnuson, Alex Kunec, Eric Deutsch
  • Publication number: 20210187540
    Abstract: A pipe doping apparatus comprises a bucket assembly including a base and a bucket supported on the base and having an inside volume, a lubricating unit having at least one lubricant applicator inside the bucket; and a source of torque configured to rotate the bucket and/or the lubricating unit relative to a tubular. The apparatus may include a cleaning unit and/or a drying unit and the source of torque may be a fluid jet in either. At least one lubricant applicator may be retractable and may be actuated between a retracted position and an extended position by centripetal force. The apparatus may further include a positioning assembly supporting the base and the rotary bucket assembly and a controller connected to and controlling each of:—the positioning assembly, the cleaning unit, the drying unit, and the lubricating unit.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 24, 2021
    Inventors: Ronald SCHANLAUB, Keith HAGER, Chris MAGNUSON, Eric DEUTSCH
  • Patent number: 11021442
    Abstract: A process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol including the following steps: a) the reaction of a solution of amifostine with a strong acid, to obtain a solution of 2-[(3-aminopropyl)amino]ethanethiol, and b) the freeze-drying of the solution of 2-[(3-aminopropyl)amino]ethanethiol, with or without addition of excipients.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: June 1, 2021
    Assignees: CLEVEXEL PHARMA, INSTITUT GUSTAVE ROUSSY
    Inventors: Xiuping Wang-Zhang, Perrine Pivette, Karine Gonzalez, Eric Deutsch, Céline Clemenson
  • Publication number: 20210128730
    Abstract: The invention relates to methods for treating tumors. In particular, the invention provides novel use of nanoparticles in combination with ionizing radiations for treating tumors, wherein the combined effect of nanoparticles induces senescence and/or cannibalism of the tumor cells.
    Type: Application
    Filed: July 4, 2018
    Publication date: May 6, 2021
    Inventors: François LUX, Olivier TILLEMENT, Jean-Luc PERFETTINI, Eric DEUTSCH, Frédéric LAW, Awatef ALLOUCH